drugset / Trial / NCT00800280

Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body

NCT00800280

Phase 1 Terminated 12 enrolled Pfizer
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to estimate the effects of multiple doses of cimetidine on the pharmacokinetics of a single dose of PD 0332334 and to evaluate the safety and tolerability of PD 0332334 when co-administered with cimetidine.

Timeline

Start
2009-01
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cimetidine Small molecule 600 mg Oral
Subject IMAGABALIN Other / unclassified 300 mg Oral